Cardioptimus LLC has developed the Embolisher. This patent-pending embolic deflection device, when deployed within the aortic arch, deflects emboli down the descending aorta to prevent neurological dysfunctions such as stroke. The Embolisher is introduced into the aortic arch via transfemoral catheterization at the beginning of the procedure and remains completely detached from the outside environment for the operation’s duration. Once complete, the implant is retrieved via a novel catheter developed specifically for minimizing operator time and effort.
The Embolisher safely conforms to the aortic arch while maintaining a superior seal within the aorta, yet has minimal interfacial contact, which reduces the risk of irritation. While in place, additional catheters – such as those carrying valve implants – are able to pass through the device. Ease of deployment and retrieval with radioscopic imaging and additional patent-pending technologies ensures convenient and effective use.